MAIA Biotechnology Inc (MAIA)
3.13
+0.21
(+7.19%)
USD |
NYAM |
May 02, 12:50
MAIA Biotechnology Cash from Operations (Quarterly): -3.992M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -3.992M |
| September 30, 2023 | -3.157M |
| June 30, 2023 | -2.561M |
| March 31, 2023 | -3.361M |
| December 31, 2022 | -2.950M |
| September 30, 2022 | -4.319M |
| Date | Value |
|---|---|
| June 30, 2022 | -2.019M |
| March 31, 2022 | -2.808M |
| December 31, 2021 | -1.607M |
| September 30, 2021 | -1.311M |
| June 30, 2021 | -0.951M |
| March 31, 2021 | -0.2533M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-4.319M
Minimum
Sep 2022
-0.2533M
Maximum
Mar 2021
-2.441M
Average
-2.684M
Median
Cash from Operations (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | -3.91M |
| Avid Bioservices Inc | 3.687M |
| Oragenics Inc | -1.102M |
| NeuBase Therapeutics Inc | -2.003M |
| Viking Therapeutics Inc | -6.134M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 5.025M |
| Free Cash Flow | -13.07M |
| Free Cash Flow Per Share (Quarterly) | -0.2579 |
| Free Cash Flow Yield | -31.51% |